Insulet Corporation
PODD
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 7 days ago • PODD
Here's Why Insulet (PODD) is a Strong Growth Stock
Forbes • 13 days ago • PODD
Is PODD A Better Bet Than ISRG Stock?
Seeking Alpha • 19 days ago • PODD
Insulet Corporation (PODD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Zacks Investment Research • 24 days ago • PODD
Here's Why Insulet (PODD) is a Strong Growth Stock
Business Wire • 24 days ago • PODD
Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.